Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Korean Red Ginseng for Middle-aged and Elderly Sub-health Population on Anti-oxidation
NCT05592093Phase 3Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Mar 2023
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in oxidative stress (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Malondialdehyde at 12 weeks. Started Mar 2023; status: completed.
02
Conditions
oxidative stress
Beyond the preview
Go deeper on NCT05592093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05592093.